The Carbonic Anhydrases: Current and Emerging Therapeutic Targets / Progress in Drug Research Bd.75 (PDF)
(Sprache: Englisch)
This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have...
sofort als Download lieferbar
Printausgabe 153.99 €
eBook (pdf) -36%
98.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „The Carbonic Anhydrases: Current and Emerging Therapeutic Targets / Progress in Drug Research Bd.75 (PDF)“
This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
Bibliographische Angaben
- 2021, 1st ed. 2021, 288 Seiten, Englisch
- Herausgegeben: W. Richard Chegwidden, Nicholas D. Carter
- Verlag: Springer International Publishing
- ISBN-10: 303079511X
- ISBN-13: 9783030795115
- Erscheinungsdatum: 30.10.2021
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 6.05 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "The Carbonic Anhydrases: Current and Emerging Therapeutic Targets / Progress in Drug Research Bd.75"
Schreiben Sie einen Kommentar zu "The Carbonic Anhydrases: Current and Emerging Therapeutic Targets / Progress in Drug Research Bd.75".
Kommentar verfassen